Silver Price Outlook Key Drivers and Market Expectations for the Next Decade AI Reshapes Labor Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Jobs Slow Bain Capitalbacked Dhoot Transmission Files Updated DRHP for IPO Plans Rs 1400 Crore Fresh Issue Waterfield Advisors Equities Head Suggests Staggered Accumulation as Peak Macro Concerns Subside European Telecom CEO Warns of US Satellite Dominance Risk to Continents Connectivity BristolMyers Squibb Shares Rise on AI Partnership with Anthropic Analysts See Potential Upside Catalyst URBN Q1 2026 Earnings EPS Surpasses Estimates by 114 Shares Gain 33 CLBT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response GBTG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency NU Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction OKLO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Advanced Nuclear Development ZKH Group Shares Slide Over 11 as Price Approaches Support Zone Neptune Insurance Holdings NP Edges Lower Amid Market Caution Technical Levels in Focus CarPartscom PRTS Edges Higher as Stock Consolidates Near Key Support Arcos Dorados Holdings ARCO Holds Near Support Amid Minimal Price Movement Gyre Therapeutics GYRE Falters Testing Key Support After 194 Decline Puig Plunges After Este Lauder TieUp Talks Terminated European Stocks Rise EyePoint Inc EYPT Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline VICI Properties Holds Steady Near 2850 Amid Modest Trading Activity EPM Q1 2026 Earnings Deep EPS Miss Punishes Stock as Revenue Details Remain Unreported AZZ Inc Q1 2026 Earnings Strong Earnings Beat Amid Steady Operational Performance MPB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Vertical Aerospace Q4 2025 Earnings EPS Miss Reflects Ongoing RD Investment PreRevenue Status Maintained New Found Gold Corp NFGC Q1 2026 Earnings EPS Miss Highlights Exploration Stage Challenges Arq Inc ARQ Q1 2026 Earnings EPS Beats Estimates Amid Cost Discipline TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline